SOTERA HEALTH CO

NASDAQ: SHC (Sotera Health Company)

Last update: 12 Apr, 1:24AM

15.36

0.08 (0.52%)

Previous Close 15.28
Open 15.34
Volume 1,842,724
Avg. Volume (3M) 2,500,367
Market Cap 4,380,002,816
Price / Earnings (TTM) 56.89
Price / Earnings (Forward) 16.98
Price / Sales 3.80
Price / Book 7.27
52 Weeks Range
10.17 (-33%) — 19.85 (29%)
Earnings Date 30 Apr 2026
Profit Margin 2.24%
Operating Margin (TTM) 27.86%
Diluted EPS (TTM) 0.090
Quarterly Revenue Growth (YOY) 2.60%
Quarterly Earnings Growth (YOY) -68.10%
Total Debt/Equity (MRQ) 566.88%
Current Ratio (MRQ) 2.46
Operating Cash Flow (TTM) 269.99 M
Levered Free Cash Flow (TTM) 194.97 M
Return on Assets (TTM) 7.01%
Return on Equity (TTM) 5.88%

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Mixed Bullish
Diagnostics & Research (Global) Mixed Bullish
Stock Sotera Health Company Bullish Bullish

AIStockmoo Score

1.1
Analyst Consensus 3.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators 0.5
Average 1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
SHC 4 B - 56.89 7.27
TWST 4 B - - 7.95
WGS 2 B - - 6.51
CDNA 1 B - - 3.41
CSTL 741 M - - 1.57
PRPO 51 M - - 3.89

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Small Core
% Held by Insiders 2.51%
% Held by Institutions 95.98%

Ownership

Name Date Shares Held
Warburg Pincus Llc 31 Dec 2025 34,102,952
52 Weeks Range
10.17 (-33%) — 19.85 (29%)
Median 23.00 (49.74%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
Citigroup 24 Feb 2026 23.00 (49.74%) Buy 16.72

No data within this time range.

Date Type Details
05 Feb 2026 Announcement Sotera Health Appoints Richard Kyle to the Board of Directors

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria